Published in Ther Drug Monit on April 01, 2010
Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants. Eur J Clin Pharmacol (2013) 0.82
Comparison of architect I 2000 for determination of cyclosporine with axsym. Acta Inform Med (2012) 0.75
Effects of CYP3A5 polymorphism on the pharmacokinetics of a once-daily modified-release tacrolimus formulation and acute kidney injury in hematopoietic stem cell transplantation. Cancer Chemother Pharmacol (2016) 0.75
Multicenter analytical evaluation of the automated electrochemiluminescence immunoassay for cyclosporine. Ther Drug Monit (2014) 0.75
A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, Part I. J Clin Chem Clin Biochem (1983) 5.44
Evaluation of a no-pretreatment cyclosporin A assay on the Dade Behring dimension RxL clinical chemistry analyzer. Clin Chem (2002) 1.42
Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. Clin Chem (2002) 1.23
Lack of specificity of cyclosporine immunoassays. Results of a College of American Pathologists Study. Arch Pathol Lab Med (2003) 1.04
Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Ther Drug Monit (2009) 0.99
Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem (1998) 0.96
Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. Clin Biochem (1998) 0.94
Cyclosporin: revisions in monitoring guidelines and review of current analytical methods. Ann Clin Biochem (2002) 0.91
Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem (1999) 0.86
Therapeutic drug monitoring of cyclosporine. Transplant Proc (2004) 0.84
Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem (1990) 0.83
Evaluation of EMIT Cyclosporine Assay for use with whole blood. Clin Chem (1993) 0.82
Evaluation of the new AxSYM cyclosporine assay: comparison with TDx monoclonal whole blood and Emit cyclosporine assays. Clin Chem (1999) 0.81
Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer. Clin Biochem (2009) 0.80
Identification and analysis of nine metabolites of cyclosporine in whole blood by liquid chromatography. 2: Comparison of patients' results. Clin Chem (1987) 0.79
A monoclonal antibody fluorescent polarization immunoassay for cyclosporine. Transplant Proc (1990) 0.78
Three commercial polyclonal immunoassays for cyclosporine in whole blood compared: 1. Results with patients' specimens. Clin Chem (1990) 0.78
Robotic automation of cyclosporine analysis in whole blood. Clin Chem (1992) 0.78
Inter-laboratory differences in sirolimus results from six sirolimus testing centers using HPLC tandem mass spectrometry (LC/MS/MS). Clin Chim Acta (2005) 0.78
Measurement of cyclosporine by liquid chromatography and three immunoassays in blood from liver, cardiac, and renal transplant recipients. Clin Chem (1992) 0.78
Measurement of the integral refractive index and dynamic cell morphometry of living cells with digital holographic microscopy. Opt Express (2005) 2.40
Cell refractive index tomography by digital holographic microscopy. Opt Lett (2006) 2.19
Living specimen tomography by digital holographic microscopy: morphometry of testate amoeba. Opt Express (2006) 1.94
Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil. Arthritis Rheum (2010) 1.75
Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference. Ther Drug Monit (2009) 1.68
Effects of motive-oriented therapeutic relationship in a ten-session general psychiatric treatment of borderline personality disorder: a randomized controlled trial. Psychother Psychosom (2014) 1.64
Ribavirin exposure after the first dose is predictive of sustained virological response in chronic hepatitis C. Hepatology (2008) 1.62
Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department: a multicenter prospective study. Crit Care (2013) 1.55
Simultaneous cell morphometry and refractive index measurement with dual-wavelength digital holographic microscopy and dye-enhanced dispersion of perfusion medium. Opt Lett (2008) 1.53
Comparative evaluation of serologic tests for celiac disease diagnosis and follow-up. Clin Chem (2002) 1.48
Automated segmentation of multiple red blood cells with digital holographic microscopy. J Biomed Opt (2013) 1.47
Bacterial expression of mutant argininosuccinate lyase reveals imperfect correlation of in-vitro enzyme activity with clinical phenotype in argininosuccinic aciduria. J Inherit Metab Dis (2011) 1.44
Early cell death detection with digital holographic microscopy. PLoS One (2012) 1.35
In vivo endoscopic tissue diagnostics based on spectroscopic absorption, scattering, and phase function properties. J Biomed Opt (2003) 1.34
Noninvasive characterization of the fission yeast cell cycle by monitoring dry mass with digital holographic microscopy. J Biomed Opt (2009) 1.26
Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients. Clin Pharmacokinet (2009) 1.21
Comparative study of human erythrocytes by digital holographic microscopy, confocal microscopy, and impedance volume analyzer. Cytometry A (2008) 1.20
Statistically significant changes of antimüllerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril (2007) 1.16
Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos (2004) 1.15
Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab (2008) 1.12
CYP3A5*3 influences sirolimus oral clearance in de novo and stable renal transplant recipients. Clin Pharmacol Ther (2006) 1.11
CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation. Clin Pharmacol Ther (2004) 1.10
In vitro metabolism study of buprenorphine: evidence for new metabolic pathways. Drug Metab Dispos (2005) 1.08
Essential role of the p110beta subunit of phosphoinositide 3-OH kinase in male fertility. Mol Biol Cell (2010) 1.07
Development of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assays. J Clin Microbiol (2009) 1.07
Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients. Clin Pharmacokinet (2004) 1.05
Impact of different diagnostic criteria during adrenal vein sampling on reproducibility of subtype diagnosis in patients with primary aldosteronism. Hypertension (2010) 1.05
Numerical parametric lens for shifting, magnification, and complete aberration compensation in digital holographic microscopy. J Opt Soc Am A Opt Image Sci Vis (2006) 1.04
Maximum a posteriori bayesian estimation of mycophenolic acid pharmacokinetics in renal transplant recipients at different postgrafting periods. Ther Drug Monit (2005) 1.04
The need for standardization of tacrolimus assays. Clin Chem (2011) 1.04
Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension (2011) 1.01
A double absorption-phase model adequately describes mycophenolic acid plasma profiles in de novo renal transplant recipients given oral mycophenolate mofetil. Clin Pharmacokinet (2005) 1.01
Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplant Rev (Orlando) (2010) 1.00
Determination of transmembrane water fluxes in neurons elicited by glutamate ionotropic receptors and by the cotransporters KCC2 and NKCC1: a digital holographic microscopy study. J Neurosci (2011) 1.00
Population pharmacokinetic model and Bayesian estimator for two tacrolimus formulations--twice daily Prograf and once daily Advagraf. Br J Clin Pharmacol (2011) 1.00
Automatic procedure for aberration compensation in digital holographic microscopy and applications to specimen shape compensation. Appl Opt (2006) 0.99
Multi-site analytical evaluation of the Abbott ARCHITECT tacrolimus assay. Ther Drug Monit (2009) 0.99
Epigenetic silencing and tissue independent expression of a novel tetracycline inducible system in double-transgenic pigs. FASEB J (2006) 0.99
Favourable long-term outcome after immediate treatment of neonatal hyperammonemia due to N-acetylglutamate synthase deficiency. Eur J Pediatr (2009) 0.98
Mechanisms underlying postmortem redistribution of drugs: a review. J Anal Toxicol (2003) 0.98
Contribution of the different UDP-glucuronosyltransferase (UGT) isoforms to buprenorphine and norbuprenorphine metabolism and relationship with the main UGT polymorphisms in a bank of human liver microsomes. Drug Metab Dispos (2010) 0.98
Cell morphology and intracellular ionic homeostasis explored with a multimodal approach combining epifluorescence and digital holographic microscopy. J Biophotonics (2010) 0.97
Submicrometer tomography of cells by multiple-wavelength digital holographic microscopy in reflection. Opt Lett (2009) 0.97
Association of sirolimus adverse effects with m-TOR, p70S6K or Raptor polymorphisms in kidney transplant recipients. Pharmacogenet Genomics (2012) 0.97
Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in renal transplant recipients on a new once-daily formulation. Clin Pharmacokinet (2010) 0.96
Pharmacokinetic modeling and development of Bayesian estimators in kidney transplant patients receiving the tacrolimus once-daily formulation. Ther Drug Monit (2010) 0.96
Polarization microscopy by use of digital holography: application to optical-fiber birefringence measurements. Appl Opt (2005) 0.96
Label-free second-harmonic phase imaging of biological specimen by digital holographic microscopy. Opt Lett (2010) 0.95
Contribution of nicotine to acute endothelial dysfunction in long-term smokers. J Am Coll Cardiol (2002) 0.95
Spatial analysis of erythrocyte membrane fluctuations by digital holographic microscopy. Blood Cells Mol Dis (2009) 0.94
Teratocarcinoma-derived growth factor-1 is upregulated in aldosterone-producing adenomas and increases aldosterone secretion and inhibits apoptosis in vitro. Hypertension (2010) 0.94
Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation italian pedigree. J Clin Endocrinol Metab (2002) 0.94
Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus. Clin Pharmacokinet (2009) 0.94
Application of pharmacokinetic modelling to the routine therapeutic drug monitoring of anticancer drugs. Fundam Clin Pharmacol (2002) 0.94
Antiglycan antibodies as serological markers in the differential diagnosis of inflammatory bowel disease. Inflamm Bowel Dis (2008) 0.94
Characterization of a phase 1 metabolite of mycophenolic acid produced by CYP3A4/5. Ther Drug Monit (2004) 0.94
NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α. Diabetes Care (2012) 0.94
Metabolism of sirolimus in the presence or absence of cyclosporine by genotyped human liver microsomes and recombinant cytochromes P450 3A4 and 3A5. Drug Metab Dispos (2006) 0.93
Pesticide contamination of workers in vineyards in France. J Expo Sci Environ Epidemiol (2006) 0.93
Total aberrations compensation in digital holographic microscopy with a reference conjugated hologram. Opt Express (2006) 0.93
Neonatal hyperammonemia: the N-carbamoyl-L-glutamic acid test. J Pediatr (2005) 0.93
18-hydroxycorticosterone, 18-hydroxycortisol, and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. J Clin Endocrinol Metab (2012) 0.92
Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem (2006) 0.91
Comparison of liquid chromatography-tandem mass spectrometry with a commercial enzyme-multiplied immunoassay for the determination of plasma MPA in renal transplant recipients and consequences for therapeutic drug monitoring. Ther Drug Monit (2004) 0.90
Influence of the UGT2B7 promoter region and exon 2 polymorphisms and comedications on Acyl-MPAG production in vitro and in adult renal transplant patients. Pharmacogenet Genomics (2007) 0.90
Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation. Clin Pharmacokinet (2009) 0.90
Real-time dual-wavelength digital holographic microscopy with a single hologram acquisition. Opt Express (2007) 0.90
Pharmacokinetic study of mycophenolate mofetil in patients with systemic lupus erythematosus and design of Bayesian estimator using limited sampling strategies. Clin Pharmacokinet (2008) 0.89
Sirolimus population pharmacokinetic/pharmacogenetic analysis and bayesian modelling in kidney transplant recipients. Clin Pharmacokinet (2006) 0.89
Characterization of microlenses by digital holographic microscopy. Appl Opt (2006) 0.88
Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report. Mt Sinai J Med (2005) 0.88
A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits. Nephrol Dial Transplant (2010) 0.88
A comparison of the effect of ciclosporin and sirolimus on the pharmokinetics of mycophenolate in renal transplant patients. Br J Clin Pharmacol (2006) 0.88
General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology: applications and constraints. J Sep Sci (2009) 0.87
LC-MS/MS systematic toxicological analysis: comparison of MS/MS spectra obtained with different instruments and settings. Clin Biochem (2005) 0.87
Pharmacokinetic study of tacrolimus in cystic fibrosis and non-cystic fibrosis lung transplant patients and design of Bayesian estimators using limited sampling strategies. Clin Pharmacokinet (2005) 0.87
Identification of novel mutations of the human N-acetylglutamate synthase gene and their functional investigation by expression studies. Biochim Biophys Acta (2005) 0.87
Involvement of UDP-glucuronosyltransferases UGT1A9 and UGT2B7 in ethanol glucuronidation, and interactions with common drugs of abuse. Drug Metab Dispos (2012) 0.87
Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation. Ther Drug Monit (2016) 0.86
Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep (2009) 0.86
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment. Dig Liver Dis (2011) 0.86
Time-domain optical coherence tomography with digital holographic microscopy. Appl Opt (2005) 0.86
Recognition and classification of red blood cells using digital holographic microscopy and data clustering with discriminant analysis. J Opt Soc Am A Opt Image Sci Vis (2011) 0.86
[1-Meth-oxy-3-(pyridin-2-yl)indolizin-2-yl](pyridin-2-yl)methanone. Acta Crystallogr Sect E Struct Rep Online (2012) 0.86
Label-free cytotoxicity screening assay by digital holographic microscopy. Assay Drug Dev Technol (2012) 0.86
Risk of diarrhoea in a long-term cohort of renal transplant patients given mycophenolate mofetil: the significant role of the UGT1A8 2 variant allele. Br J Clin Pharmacol (2010) 0.86
Bayesian estimation of methotrexate pharmacokinetic parameters and area under the curve in children and young adults with localised osteosarcoma. Clin Pharmacokinet (2002) 0.86
Effect of mycophenolate acyl-glucuronide on human recombinant type 2 inosine monophosphate dehydrogenase. Clin Chem (2009) 0.85
Unexplained common bile duct dilatation with normal serum liver enzymes: diagnostic yield of endoscopic ultrasound and follow-up of this condition. J Clin Gastroenterol (2014) 0.85
Pitfalls and prevention strategies for liquid chromatography-tandem mass spectrometry in the selected reaction-monitoring mode for drug analysis. Clin Chem (2008) 0.85
Automated statistical quantification of three-dimensional morphology and mean corpuscular hemoglobin of multiple red blood cells. Opt Express (2012) 0.85
Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension? J Hepatol (2005) 0.85
Current role of LC-MS in therapeutic drug monitoring. Anal Bioanal Chem (2007) 0.85
Automated quantitative analysis of 3D morphology and mean corpuscular hemoglobin in human red blood cells stored in different periods. Opt Express (2013) 0.85
Development of a lab-on-a-chip device for diagnosis of plant pathogens. Biosens Bioelectron (2011) 0.85
Submicrometer optical tomography by multiple-wavelength digital holographic microscopy. Appl Opt (2006) 0.84